Has Anca Vlasie, MD received payments from drug or device companies?

Yes. Drug and device makers reported $269 in general payments to Anca Vlasie, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anca Vlasie, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anca Vlasie, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anca Vlasie, MD

Nephrology · Westlake, OHNPI 1184931032

Payments from drug & device makers

$269in general payments, 2019–2025

Across 12 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Baxter Healthcare$82
Otsuka America Pharmaceutical, Inc.$77
Vifor Pharma, Inc.$39
Lilly USA, LLC$27
Fresenius USA Marketing, Inc.$17
Amgen$15
plus $11 from 1 others

What the payments were for

Food & beverage$19673%
Education$7327%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Baxter Healthcare	1	$82
Otsuka America Pharmaceutical, Inc.	2	$77
Vifor Pharma, Inc.	2	$39
Lilly USA, LLC	1	$27
Fresenius USA Marketing, Inc.	1	$17
Amgen	1	$15
Travere Therapeutics, Inc.	4	$11

How this compares

$269 in reported general payments places this provider in the 20th percentile of 450 nephrology providers in Ohio.

See all nephrology providers in Ohio →

Medicare billing

Part B allowed, 2024

$178,472

Medicare patients

434

Services billed

1,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LokelmaSodium Zirconium Cyclosilicate	22	$13,097
FarxigaDapagliflozin Propanediol	19	$12,626
DapagliflozinDapagliflozin Propanediol	11	$5,945
Doxazosin Mesylate	163	$2,290
Potassium Chloride	67	$1,941
Sevelamer Carbonate	15	$1,741
Calcitriol	144	$1,621
Tamsulosin Hcl	147	$1,502
Nifedipine ErNifedipine	42	$1,466
Allopurinol	191	$1,387
Potassium Citrate ErPotassium Citrate	13	$1,285
Amlodipine Besylate	255	$904
Candesartan Cilexetil	11	$849
Hydralazine Hcl	49	$810
Metoprolol Succinate	58	$804

Paid to pharmacies, not to this prescriber.

Other nephrology in Westlake

Arash RashidiWestlake$113K
Isabelle AyoubColumbus$1.6M
Andrew LazarBeachwood$806K
Samir ParikhColumbus$699K
Brad RovinColumbus$625K
Lance DworkinToledo$601K
Mohamed SekkarieToledo$524K
Kevin SchroederColumbus$518K
Prabir Roy ChaudhuryCincinnati$483K
Amit GovilCincinnati$444K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →